SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-17-032362
Filing Date
2017-05-12
Accepted
2017-05-12 17:20:11
Documents
3
Period of Report
2017-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a17-12882_28ka.htm 8-K/A 23170
2 EX-99.1 a17-12882_2ex99d1.htm EX-99.1 186622
3 GRAPHIC g128822mm01i001.gif GRAPHIC 4012
  Complete submission text file 0001104659-17-032362.txt   216554
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37558 | Film No.: 17839956
SIC: 2834 Pharmaceutical Preparations